MAPK3 and prostate cancer: In prostate cancer cells, a reduction in the expression of POMT1 and other glycosyltransferases, which are involved in the biosynthesis of the matriglycan (B4GAT1, LARGE), also leads to the activation of ERK1/2 (29).